Publications

These publications were authored or co-authored by Quest Diagnostics staff.

The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers into breast cancer clinical trials and daily practice.

Authors: Gonzalez-Ericsson PI, Stovgaard ES, Sua LF, Reisenbichler E, Kos Z, Carter JM, Michiels S, Le Quesne J, Nielsen TO, Laenkholm AV, Fox SB, Adam J, Bartlett JM, Rimm DL, Quinn C, Peeters D, Dieci MV, Vincent-Salomon A, Cree I, Hida AI, Balko JM, Haynes HR, Frahm I, Acosta-Haab G, Balancin M, Bellolio E, Yang W, Kirtani P, Sugie T, Ehinger A, Castaneda CA, Kok M, McArthur H, Siziopikou K, Badve S, Fineberg S, Gown A, Viale G, Schnitt SJ, Pruneri G, Penault-Llorca F, Hewitt S, Thompson EA, Allison KH, Symmans WF, Bellizzi AM, Brogi E, Moore DA, Larsimont D, Dillon DA, Lazar A, Lien H, Goetz MP, Broeckx G, El Bairi K, Harbeck N, Cimino-Mathews A, Sotiriou C, Adams S, Liu SW, Loibl S, Chen IC, Lakhani SR, Juco JW, Denkert C, Blackley EF, Demaria S, Leon-Ferre R, Gluz O, Zardavas D, Emancipator K, Ely S, Loi S, Salgado R, Sanders M; International Immuno-Oncology Biomarker Working Group.
J Pathol. 2020 Apr;250:667-684. doi: 10.1002/path.5406. Epub 2020 Apr 9.

Specialties: Oncology

Disclaimer: One or more of the authors of this publication were employed at the time by , a subsidiary of Quest Diagnostics.

Reply to 'Comment on "Histopathologic features distinguishing secondary syphilis from its mimickers".

Authors: Flamm A, Alcocer VM, Kazlouskaya V, Kwon EJ, Elston D.
J Am Acad Dermatol. 2020 Apr. pii: S0190-9622(20)30531-4. doi: 10.1016/j.jaad.2020.03.106. [Epub ahead of print]

Specialties: Dermatology

Disclaimer: One or more of the authors of this publication were employed at the time by DermPath, a subsidiary of Quest Diagnostics.

S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) - short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow-up, prevention and occupational disease.

Authors: Leiter U, Heppt MV, Steeb T, Amaral T, Bauer A, Becker JC, Breitbart E, Breuninger H, Diepgen T, Dirschka T, Eigentler T, Flaig M, Follmann M, Fritz K, Greinert R, Gutzmer R, Hillen U, Ihrler S, John SM, Kölbl O, Kraywinkel K, Löser C, Nashan D, Noor S, Nothacker M, Pfannenberg C, Salavastru C, Schmitz L, Stockfleth E, Szeimies RM, Ulrich C, Welzel J, Wermker K, Garbe C, Berking C.
J Dtsch Dermatol Ges. 2020 Apr;18:400-413. doi: 10.1111/ddg.14072. Epub 2020 Apr 4.

Specialties: Dermatology

Disclaimer: One or more of the authors of this publication were employed at the time by DermPath, a subsidiary of Quest Diagnostics.

SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours.

Authors: Hoskoppal D, Epstein JI, Gown AM, Arnold Egloff SA, Gordetsky JB, Shi CJ, Giannico GA.
Histopathology. 2020 Mar;76:550-559. doi: 10.1111/his.14012. Epub 2020 Jan 24.

Specialties: Oncology

Disclaimer: One or more of the authors of this publication were employed at the time by , a subsidiary of Quest Diagnostics.

S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma - short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality-of-care indicators.

Authors: Heppt MV, Leiter U, Steeb T, Amaral T, Bauer A, Becker JC, Breitbart E, Breuninger H, Diepgen T, Dirschka T, Eigentler T, Flaig M, Follmann M, Fritz K, Greinert R, Gutzmer R, Hillen U, Ihrler S, John SM, Kölbl O, Kraywinkel K, Löser C, Nashan D, Noor S, Nothacker M, Pfannenberg C, Salavastru C, Schmitz L, Stockfleth E, Szeimies RM, Ulrich C, Welzel J, Wermker K, Berking C, Garbe C.
Histopathology. 2020 Mar;76:550-559. doi: 10.1111/his.14012. Epub 2020 Jan 24.

Specialties: Dermatology

Disclaimer: One or more of the authors of this publication were employed at the time by DermPath, a subsidiary of Quest Diagnostics.

Localized vitiligo occurring in an old biopsy scar: A case report.

Authors: Rychik K, Cohen J, Glass A.
JAAD Case Rep. 2020 Mar 25;6:326-328. doi: 10.1016/j.jdcr.2020.02.003. eCollection 2020 Apr.

Specialties: Dermatology

Disclaimer: One or more of the authors of this publication were employed at the time by DermPath, a subsidiary of Quest Diagnostics.

Salivary ghost cell carcinoma: case report and proposal of a new entity.

Authors: Ihrler S, Mollenhauer M, Weitmayr B, Haas CJ.
Virchows Arch. 2020 Mar;476(3):465-468.

Specialties: Dermatology, Oncology

Disclaimer: One or more of the authors of this publication were employed at the time by DermPath, a subsidiary of Quest Diagnostics.

Mycoplasma genitalium detection in urogenital specimens from symptomatic and asymptomatic men and women using the cobas TV/MG test.

Authors: Van Der Pol B, Waites KB, Xiao L, Taylor SN, Rao A, Nye M, Chavoustie S, Ermel A, Kaplan C, Eisenberg D, Chan PA, Mena L, Pacheco S, Krishnamurthy S, Mohan R, Bertuzis R, McGowin CL, Arcenas R, Marlowe EM.
J Clin Microbiol. 2020 Mar 25. pii: JCM.02124-19. doi: 10.1128/JCM.02124-19. [Epub ahead of print]

Specialties: Infectious Disease

Peripheral Palisading in Melanoma Mimicking Basal Cell Carcinoma: A Case Report.

Authors: Wang Y, Guo Y.
Am J Dermatopathol. 2020 Mar. doi: 10.1097/DAD.0000000000001636. [Epub ahead of print]

Specialties: Dermatology

Disclaimer: One or more of the authors of this publication were employed at the time by Ackerman Academy, a subsidiary of Quest Diagnostics.

Erythema Migrans and Interface Changes: More Than a Fortuitous Association.

Authors: Tekin B, Song Y, DiCostanzo D, Lee BA.
Am J Dermatopathol. 2020 Mar doi: 10.1097/DAD.0000000000001631. [Epub ahead of print]

Specialties: Dermatology

Disclaimer: One or more of the authors of this publication were employed at the time by DermPath, a subsidiary of Quest Diagnostics.